The immunohistochemistry assay revealed that NCX1 expression was higher in prostate cancer tissues than in benign prostatic hyperplasia tissues (Figure 1A), and NCX1 expression increased as prostate cancer grade increased. This evidence concerns the gene SLC8A1 and prostate carcinoma.